The Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections

NCT06990126 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-01-06

No results posted yet for this study

Summary

A multicenter, retrospective, real-world stduy . Subjects with composite criteria were teated with eravacycline ,and 100 cases ,Tigecycline and 300 cases were to be enrolled.

Conditions

  • Clinical Efficacy and Safety

Interventions

DRUG

bronchoscope

We will perform bronchoscopy and collect bronchoalveolar lavage fluid(BALF)

Sponsors & Collaborators

  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2026-07-30
Completion
2026-07-30
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06990126 on ClinicalTrials.gov